Financial Performance - Net Sales for Q4 2024 decreased by 10.1% to 140.1millioncomparedto155.7 million in Q4 2023[6] - Full Year 2024 Net Sales decreased by 8.7% to 602.2millioncomparedto659.7 million in 2023[6] - Net Loss for Q4 2024 was (37.8)million,or(0.32) per diluted share, compared to Net Income of 1.2million,or0.01 per diluted share in Q4 2023[6] - Adjusted Net Income for Q4 2024 was 12.6millioncomparedtoanAdjustedNetLossof(0.5) million in Q4 2023[6] - Net loss for the thirteen weeks ended December 31, 2024, was 37,782thousand,comparedtoanetincomeof1,202 thousand for the same period in 2023[32] - Adjusted EBITDA for the year ended December 31, 2024, was 110,493thousand,downfrom130,885 thousand in 2023, reflecting a decrease of approximately 15.6%[32] - The Adjusted EBITDA Margin for the year ended December 31, 2024, was 18.3%, compared to 19.8% in 2023, indicating a decline in operational efficiency[32] - The net income margin for the year ended December 31, 2024, was -3.9%, compared to a positive margin of 2.9% in 2023[32] - Adjusted Net Income for the year ended December 31, 2024, was 24,838thousand,comparedto25,040 thousand in 2023, showing a slight decrease[36] Cash Flow and Assets - The company reported a net cash provided by operating activities of 4.126millionforthethirteenweeksendedDecember31,2024,comparedto31.229 million in the prior year[27] - Net cash provided by operating activities for the year ended December 31, 2024, was 46,899thousand,downfrom88,092 thousand in 2023[38] - Cash and cash equivalents increased to 56.087millionasofDecember31,2024,comparedto41.081 million at the end of 2023[25] - Total assets decreased to 1,133.320millionasofDecember31,2024,downfrom1,203.343 million as of December 31, 2023[25] - Total liabilities decreased to 712.168millionasofDecember31,2024,from762.192 million as of December 31, 2023[25] Operational Metrics - Adjusted EBITDA for Full Year 2024 was 110.5million,downfrom130.9 million in 2023[11] - Free Cash Flow for the year ended December 31, 2024, was 41,821thousand,adecreasefrom83,639 thousand in 2023, representing a decline of approximately 50%[38] - The Bank-adjusted EBITDA Leverage Ratio as of December 31, 2024, was 4.17x, indicating a significant level of debt relative to earnings[34] - Research and development costs for the year ended December 31, 2024, were 18.710million,adecreaseof21.523.844 million in 2023[23] - Inventory turns improved to 2.0x compared to 1.9x last year[13] Strategic Developments - A perpetual exclusive license agreement with Cataclean for the North American market was announced for a total purchase price of 23.8million[13]−FullYear2025revenueguidanceindicatesexpectedgrowthof0.8580 - 600million[12]−Direct−to−Consumer(DTC)andNationalRetailergrowthwas8100 million[5] Impairments and Restructuring - The company reported an impairment of goodwill amounting to 40,906thousandfortheyearendedDecember31,2024[34]−Thecompanyincurredrestructuringcostsof1,372 thousand for the year ended December 31, 2024[34] Income and Loss Analysis - Operating income for the thirteen weeks ended December 31, 2024, was a loss of 28.981million,adeclineof254.218.790 million in 2023[23] - Gross profit increased by 6.0% to 63.886millionforthethirteenweeksendedDecember31,2024,comparedto60.254 million in the prior year[23]